Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, our latest releases, and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health is a Finnish health technology company that aims to promote preventative health and help people stay healthy. Our blood analysis technology measures a large variety of biomarkers from a single blood sample and identifies personal risks for disease using unique health data assets. We provide people with comprehensive insights on health, help them make better decisions regarding their health and connect them with healthcare experts that offer preventative services for maintaining health. We strive to help millions of people prevent common lifestyle diseases in the future and, at the same time, to reduce the immense expenses of healthcare.
Contact us
ir@nightingalehealth.com
Share graph
Half-year report published
Nightingale Health Group’s Half-year report 1 July 2022 – 31 December 2022: Commercialization progressing in line with strategy
Extraordinary General Meeting 2023
Extraordinary General Meeting will be held on Monday, 24 April 2023, beginning at 4:00 p.m. (EEST).
Latest releases
Nightingale Health Group’s Half-year report 1 July 2022 – 31 December 2022: Commercialization progressing in line with strategy
Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods
Nightingale Health to publish half-year report for July – December 2022 on 23 March 2023
Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples
Nightingale Health combines genetics with its unique blood test results in Livit by Nightingale Health service
Inside information: Nightingale Health acquires worldwide license for blood self-collection device Velvet™
Nightingale Health Plc – Managers’ transactions – Leena Niemistö
Nightingale Health Plc – Managers’ transactions – Leena Niemistö
Change in the publication date of Nightingale Health Plc’s half-year financial report for the period 1 July – 31 December 2022
